Wang Yizhong, Li Jieliang, Wang Xu, Zhou Yu, Zhang Ting, Ho Wenzhe
Department of Infectious Diseases, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Department of Pathology and Laboratory Medicine, School of Medicine, Temple University, Philadelphia, USA.
Hepat Mon. 2015 Aug 30;15(8):e29282. doi: 10.5812/hepatmon.29282. eCollection 2015 Aug.
Macrophages play critical roles in innate immune response in the liver. Whether macrophages participate in liver innate immunity against HCV replication is poorly understood.
The aim of this study was to investigate the role of macrophages in liver innate immunity against HCV replication.
Freshly isolated monocytes were purified from peripheral blood of healthy adult donors. Macrophages refer to 7-day-cultured monocytes in vitro. A hepatoma cell line (Huh7) was infected with HCV JFH-1 to generate in vitro HCV infectious system. RT-PCR was used to determine HCV RNA and mRNA levels of genes expression. ELISA was used to measure the protein level of interferon-α (IFN-α) and western blot was used to determine protein expression level of Toll-like receptor 3 (TLR3).
HCV dsRNA induced the expression of type I IFN (IFN-α/β) in monocyte-derived macrophages. HCV dsRNA also induced the expression of TLR3 and IFN regulatory factor-7 (IRF-7), the key regulators of the IFN signaling pathway. When HCV JFH-1-infected Huh7 cells were co-cultured with macrophages activated with HCV dsRNA or incubated in media conditioned with supernatant (SN) from HCV dsRNA-activated macrophages, HCV replication was significantly suppressed. This macrophage SN action on HCV inhibition was mediated through type I IFN, which was evidenced by the observation that antibody to type I IFN receptor could neutralize the macrophages-mediated anti-HCV effect. The role of type I IFN in macrophages-mediated anti-HCV activity is further supported by the observation that HCV dsRNA-activated macrophages SN treatment induced the expression of several IFN-stimulated genes (ISGs), ISG15, ISG56, OAS-1, OAS-2, MxA and Viperin in HCV-infected Huh7 cells.
Macrophages may play an important role in liver innate immunity against HCV replication through a type I IFN-dependent mechanism.
巨噬细胞在肝脏的固有免疫反应中发挥关键作用。巨噬细胞是否参与肝脏针对丙型肝炎病毒(HCV)复制的固有免疫尚不清楚。
本研究旨在探讨巨噬细胞在肝脏针对HCV复制的固有免疫中的作用。
从健康成年供体的外周血中纯化新鲜分离的单核细胞。巨噬细胞指体外培养7天的单核细胞。用人肝癌细胞系(Huh7)感染HCV JFH-1以建立体外HCV感染系统。采用逆转录聚合酶链反应(RT-PCR)测定HCV RNA及基因表达的mRNA水平。采用酶联免疫吸附测定(ELISA)检测干扰素-α(IFN-α)蛋白水平,采用蛋白质印迹法检测Toll样受体3(TLR3)蛋白表达水平。
HCV双链RNA(dsRNA)诱导单核细胞来源的巨噬细胞表达I型干扰素(IFN-α/β)。HCV dsRNA还诱导IFN信号通路的关键调节因子TLR3和干扰素调节因子7(IRF-7)的表达。当HCV JFH-1感染的Huh7细胞与经HCV dsRNA激活的巨噬细胞共培养,或在经HCV dsRNA激活的巨噬细胞上清液(SN)处理过的培养基中孵育时,HCV复制受到显著抑制。巨噬细胞SN对HCV的抑制作用是通过I型干扰素介导的,这一观点得到如下观察结果的证实:I型干扰素受体抗体可中和巨噬细胞介导的抗HCV效应。HCV dsRNA激活的巨噬细胞SN处理可诱导HCV感染的Huh7细胞中多种干扰素刺激基因(ISG),即ISG15、ISG56、2'-5'-寡腺苷酸合成酶1(OAS-1)、OAS-2、Mx蛋白A(MxA)和蝰蛇毒素(Viperin)的表达,这进一步支持了I型干扰素在巨噬细胞介导的抗HCV活性中的作用。
巨噬细胞可能通过I型干扰素依赖性机制在肝脏针对HCV复制的固有免疫中发挥重要作用。